TaiwanJ Pharmaceuticals (TPEX:6549) - Stock Price, News & Analysis

6549 Stock Overview

A specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan. More details

6549 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Rewards

Earnings have grown 12.3% per year over the past 5 years

Risk Analysis

Makes less than USD$1m in revenue (NT$0)

Does not have a meaningful market cap (NT$747M)

Shareholders have been diluted in the past year

TaiwanJ Pharmaceuticals Co., Ltd. Competitors

Pharmigene

TPEX:7595

NT$767.1m

Eusol BiotechLtd

TPEX:6652

NT$1.0b

Bioray Biotech

TPEX:7561

NT$611.6m

NeoCore Technology

TPEX:4131

NT$1.1b

Price History & Performance

Summary of all time highs, changes and price drops for TaiwanJ Pharmaceuticals
Historical stock prices
Current Share Price	NT$9.32
52 Week High	NT$18.60
52 Week Low	NT$8.91
Beta	-0.45
11 Month Change	-7.26%
3 Month Change	-14.50%
1 Year Change	-41.93%
33 Year Change	-3.72%
5 Year Change	-12.98%
Change since IPO	-81.36%

Recent updates

Companies Like TaiwanJ Pharmaceuticals (GTSM:6549) Are In A Position To Invest In Growth

Apr 14

Will TaiwanJ Pharmaceuticals (GTSM:6549) Spend Its Cash Wisely?

Dec 29

Shareholder Returns

	6549	TW Biotechs	TW Market
7D	-1.3%	-3.1%	-0.8%
1Y	-41.9%	2.0%	29.0%

Return vs Industry: 6549 underperformed the TW Biotechs industry which returned 2% over the past year.

Return vs Market: 6549 underperformed the TW Market which returned 29% over the past year.

Price Volatility

Is 6549's price volatile compared to industry and market?
6549 volatility
6549 Average Weekly Movement	3.9%
Biotechs Industry Average Movement	4.5%
Market Average Movement	4.5%
10% most volatile stocks in TW Market	8.0%
10% least volatile stocks in TW Market	2.1%

Stable Share Price: 6549 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 6549's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2011	12	Rich Yuan	www.taiwanj.com

TaiwanJ Pharmaceuticals Co., Ltd., a specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan. The company also develops JKB-122 and JKB-121; and novel chemical entities for therapy to address chronic liver diseases and allergy/asthma. Its products target various diseases that include liver inflammation/liver fibrosis, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, autoimmune diseases, asthma, and atopic dermatitis.

TaiwanJ Pharmaceuticals Co., Ltd. Fundamentals Summary

How do TaiwanJ Pharmaceuticals's earnings and revenue compare to its market cap?
6549 fundamental statistics
Market cap	NT$746.74m
Earnings (TTM)	-NT$27.75m
Revenue (TTM)	n/a

0.0x

P/S Ratio

-26.9x

P/E Ratio

Is 6549 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6549 income statement (TTM)
Revenue	NT$0
Cost of Revenue	NT$0
Gross Profit	NT$0
Other Expenses	NT$27.76m
Earnings	-NT$27.75m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.35
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0%

How did 6549 perform over the long term?

See historical performance and comparison

TaiwanJ Pharmaceuticals TPEX:6549 Stock Report